CNS Co.,Ltd.

As of May 31, 2026, CNS Co.,Ltd. carries a market capitalization of 4.78B, placing it among publicly traded companies globally. Its enterprise value stands at 1.00B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

CNS Co.,Ltd.'s next confirmed earnings release is scheduled for January 8, 2027.

As of May 31, 2026, CNS Co.,Ltd. has 2.91M shares outstanding.

These figures are as of May 31, 2026.

As of May 31, 2026, CNS Co.,Ltd. maintains a current ratio of 4.47, meaning it holds 4.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended May 31, 2026.

As of the close on October 22, 2026, CNS Co.,Ltd.'s stock has gained approximately 16.17% over the past 52 weeks. The 50-day moving average sits at 1,973.12, while the 200-day moving average is 1,787.51.

As of May 31, 2026, CNS Co.,Ltd. holds 3.79B in cash and equivalents against 5.05M in total debt, resulting in a net debt position of -3.79B. Total book value stands at 4.33B, with working capital of 3.72B providing operational flexibility.